Techno Medica Co., Ltd. (6678.T)
JPY 1791.0
(-0.39%)
JPY 1791.0
(-0.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.84 Billion JPY | 11.57% |
| 2022 | 1.64 Billion JPY | -11.41% |
| 2021 | 1.86 Billion JPY | 15.8% |
| 2020 | 1.6 Billion JPY | 27.83% |
| 2019 | 1.25 Billion JPY | -17.13% |
| 2018 | 1.51 Billion JPY | 1.75% |
| 2017 | 1.49 Billion JPY | 5.14% |
| 2016 | 1.41 Billion JPY | -13.55% |
| 2015 | 1.64 Billion JPY | -29.28% |
| 2014 | 2.32 Billion JPY | 7.62% |
| 2013 | 2.15 Billion JPY | 11.11% |
| 2012 | 1.94 Billion JPY | 6.1% |
| 2011 | 1.82 Billion JPY | 26.01% |
| 2010 | 1.45 Billion JPY | 14.2% |
| 2009 | 1.27 Billion JPY | -8.1% |
| 2008 | 1.38 Billion JPY | 0.64% |
| 2007 | 1.37 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 250.56 Million JPY | -72.53% |
| 2023 Q4 | 912.2 Million JPY | 125.54% |
| 2023 FY | 1.84 Billion JPY | 11.57% |
| 2023 Q1 | 81.56 Million JPY | -90.12% |
| 2023 Q2 | 442 Million JPY | 441.9% |
| 2023 Q3 | 404.46 Million JPY | -8.49% |
| 2022 Q4 | 825.51 Million JPY | 118.72% |
| 2022 FY | 1.64 Billion JPY | -11.41% |
| 2022 Q1 | 121.78 Million JPY | -86.28% |
| 2022 Q2 | 324.71 Million JPY | 166.62% |
| 2022 Q3 | 377.43 Million JPY | 16.23% |
| 2021 Q4 | 887.69 Million JPY | 191.57% |
| 2021 FY | 1.86 Billion JPY | 15.8% |
| 2021 Q1 | 246.12 Million JPY | -70.47% |
| 2021 Q2 | 423.59 Million JPY | 72.11% |
| 2021 Q3 | 304.45 Million JPY | -28.13% |
| 2020 Q4 | 833.58 Million JPY | 125.57% |
| 2020 Q3 | 369.54 Million JPY | 13.83% |
| 2020 Q2 | 324.65 Million JPY | 305.72% |
| 2020 Q1 | 80.01 Million JPY | -80.07% |
| 2020 FY | 1.6 Billion JPY | 27.83% |
| 2019 Q3 | 250.44 Million JPY | -31.78% |
| 2019 Q4 | 401.48 Million JPY | 60.3% |
| 2019 Q1 | 238.71 Million JPY | -63.95% |
| 2019 Q2 | 367.11 Million JPY | 53.79% |
| 2019 FY | 1.25 Billion JPY | -17.13% |
| 2018 Q4 | 662.1 Million JPY | 235.07% |
| 2018 FY | 1.51 Billion JPY | 1.75% |
| 2018 Q3 | 197.6 Million JPY | -59.27% |
| 2018 Q2 | 485.17 Million JPY | 180.58% |
| 2018 Q1 | 172.91 Million JPY | -73.26% |
| 2017 FY | 1.49 Billion JPY | 5.14% |
| 2017 Q3 | 433.29 Million JPY | 118.16% |
| 2017 Q2 | 198.61 Million JPY | -6.78% |
| 2017 Q1 | 213.05 Million JPY | -67.38% |
| 2017 Q4 | 646.68 Million JPY | 49.25% |
| 2016 Q3 | 430.2 Million JPY | 548.97% |
| 2016 FY | 1.41 Billion JPY | -13.55% |
| 2016 Q4 | 653.17 Million JPY | 51.83% |
| 2016 Q2 | 66.29 Million JPY | -75.36% |
| 2016 Q1 | 269.01 Million JPY | -53.13% |
| 2015 Q1 | 418.34 Million JPY | -59.21% |
| 2015 Q3 | 131.11 Million JPY | -82.26% |
| 2015 FY | 1.64 Billion JPY | -29.28% |
| 2015 Q4 | 573.95 Million JPY | 337.73% |
| 2015 Q2 | 739.29 Million JPY | 76.72% |
| 2014 Q2 | 811.14 Million JPY | 267.07% |
| 2014 Q1 | 220.98 Million JPY | -75.62% |
| 2014 Q4 | 1.02 Billion JPY | 290.71% |
| 2014 FY | 2.32 Billion JPY | 7.62% |
| 2014 Q3 | 262.5 Million JPY | -67.64% |
| 2013 FY | 2.15 Billion JPY | 11.11% |
| 2013 Q2 | 662.63 Million JPY | 132.6% |
| 2013 Q1 | 284.88 Million JPY | -65.94% |
| 2013 Q4 | 906.54 Million JPY | 200.22% |
| 2013 Q3 | 301.95 Million JPY | -54.43% |
| 2012 Q3 | 314.05 Million JPY | -40.23% |
| 2012 Q2 | 525.44 Million JPY | 98.66% |
| 2012 FY | 1.94 Billion JPY | 6.1% |
| 2012 Q1 | 264.49 Million JPY | -66.93% |
| 2012 Q4 | 836.35 Million JPY | 166.31% |
| 2011 Q2 | 465.72 Million JPY | 159.62% |
| 2011 Q1 | 179.38 Million JPY | -76.9% |
| 2011 FY | 1.82 Billion JPY | 26.01% |
| 2011 Q3 | 383.79 Million JPY | -17.59% |
| 2011 Q4 | 799.89 Million JPY | 108.41% |
| 2010 Q1 | 101.89 Million JPY | -81.87% |
| 2010 Q3 | 133.89 Million JPY | -69.5% |
| 2010 Q2 | 438.93 Million JPY | 330.79% |
| 2010 FY | 1.45 Billion JPY | 14.2% |
| 2010 Q4 | 776.59 Million JPY | 480.0% |
| 2009 FY | 1.27 Billion JPY | -8.1% |
| 2009 Q2 | 461.13 Million JPY | 290.67% |
| 2009 Q1 | 118.03 Million JPY | -76.87% |
| 2009 Q3 | 129.8 Million JPY | -71.85% |
| 2009 Q4 | 561.87 Million JPY | 332.85% |
| 2008 Q4 | 510.24 Million JPY | 93.06% |
| 2008 Q2 | 565.59 Million JPY | 0.0% |
| 2008 Q3 | 264.29 Million JPY | -53.27% |
| 2008 FY | 1.38 Billion JPY | 0.64% |
| 2007 FY | 1.37 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DVx Inc. | 653.15 Million JPY | -181.746% |
| Seikagaku Corporation | 433 Million JPY | -324.997% |
| Eiken Chemical Co., Ltd. | 3.37 Billion JPY | 45.507% |
| Create Medic Co., Ltd. | 803.24 Million JPY | -129.1% |
| PHC Holdings Corporation | 8.31 Billion JPY | 77.861% |
| Rion Co., Ltd. | 3.47 Billion JPY | 47.042% |
| Nihon Kohden Corporation | 19.59 Billion JPY | 90.607% |
| Fukuda Denshi Co., Ltd. | 26.5 Billion JPY | 93.057% |
| Japan Lifeline Co., Ltd. | 10.89 Billion JPY | 83.105% |
| Japan Medical Dynamic Marketing, INC. | 1.74 Billion JPY | -5.342% |
| 3-D Matrix, Ltd. | -2.11 Billion JPY | 186.925% |
| CYBERDYNE Inc. | -1.73 Billion JPY | 206.004% |